Get Your Personalized Supplement StackSupplement Stack Quiz

BPC 157 Arginine Salt Equivalent

Q: Is BPC 157 Arginine Salt safe for human use?

Human safety data are insufficient; animal studies show no toxicity at tested doses. Consult with a healthcare professional before use.

Q: How quickly does BPC 157 work?

In animal models, healing benefits appear within days to weeks post-administration. Human data is needed to confirm these findings.

Q: Does the arginine salt form improve effectiveness?

Designed to enhance absorption, but direct comparative human data are lacking. More research is needed to confirm this.

Q: Are there known drug interactions?

Potential interactions with nitric oxide-related drugs are suggested in preclinical studies. Consult with a healthcare provider.

Q: Is BPC 157 approved for medical use?

No regulatory approval for human therapeutic use as of current data. It is primarily used in research settings.

Also known as: BPC 157, Body Protection Compound 157, Pentadecapeptide BPC 157, BPC 157 Arginine Salt Equivalent

Overview

BPC 157, a synthetic peptide consisting of 15 amino acids derived from a partial sequence of body protection compound (BPC) found in human gastric juice, is investigated for its regenerative and healing properties. The 'Arginine Salt Equivalent' refers to a salt form combined with arginine, potentially enhancing stability or absorption. It is not naturally occurring in dietary sources but is synthesized for therapeutic use. Primary uses include healing of the gastrointestinal tract, muscle and tendon repair, and protection against tissue injuries. BPC 157 exhibits pleiotropic effects, acting on multiple biological pathways related to tissue repair, angiogenesis, and anti-inflammatory processes. Research is primarily preclinical and animal studies, with limited human clinical trials. Evidence is largely from animal models, and high-quality randomized controlled trials (RCTs) in humans are scarce.

Benefits

BPC 157 has demonstrated accelerated healing of gastrointestinal lesions in animal models, including esophagogastric anastomosis in rats, with significant attenuation of gastric and esophageal lesions and improved anastomotic strength (p < 0.05). It has also shown prevention of lethal outcomes and attenuation of weight loss in rat models after esophagogastric surgery. Secondary effects include enhanced sphincter function and increased pressure in the esophagus and pyloric sphincter. While some suggest potential muscle and joint recovery benefits, these are not robustly quantified in clinical studies. These benefits are primarily observed in animal models of gastrointestinal injury and muscle/tendon damage, as human data are insufficient. In animal models, BPC 157 at microgram and nanogram doses significantly improved healing metrics and survival rates within days to weeks post-injury.

How it works

BPC 157 promotes angiogenesis (formation of new blood vessels) and cytoprotection. It modulates the nitric oxide (NO) system, interacting with L-arginine and L-NAME pathways, influencing vascular tone and healing. It acts on the gastrointestinal tract, vascular system, and musculoskeletal system. Molecular targets include endothelial cells, smooth muscle cells, and possibly nerve cells involved in tissue repair. The arginine salt form is designed to enhance absorption and bioavailability, though direct pharmacokinetic data in humans are limited. Its effects are mediated through multiple pathways, contributing to its broad regenerative properties.

Side effects

Animal studies report no significant toxicity or adverse effects at therapeutic doses; however, human safety data are limited. Common, uncommon, and rare side effects are not well documented in humans due to the lack of extensive clinical trials. Potential interactions with nitric oxide modulators (e.g., L-arginine, L-NAME) are suggested by animal studies. Contraindications are not established, and there is no data available for special populations. Due to the limited human data, caution is advised, and individuals should consult with a healthcare professional before using BPC 157. Further research is needed to fully characterize its safety profile in humans.

Dosage

In animal studies, effective doses of BPC 157 ranged from 10 ng/kg to 10 μg/kg. Optimal dosage ranges for humans are not established; animal studies suggest low microgram to nanogram doses are effective. The maximum safe dose in humans is not defined. In animal models, it is administered post-injury, with repeated dosing over days. The arginine salt form may improve oral absorption. Stability in the gastric environment and enhanced absorption with the arginine salt form are noted. Interaction with L-arginine and nitric oxide pathways is also noted. Due to the lack of human data, it is crucial to consult with a healthcare professional to determine appropriate and safe dosing.

FAQs

Is BPC 157 Arginine Salt safe for human use?

Human safety data are insufficient; animal studies show no toxicity at tested doses. Consult with a healthcare professional before use.

How quickly does BPC 157 work?

In animal models, healing benefits appear within days to weeks post-administration. Human data is needed to confirm these findings.

Does the arginine salt form improve effectiveness?

Designed to enhance absorption, but direct comparative human data are lacking. More research is needed to confirm this.

Are there known drug interactions?

Potential interactions with nitric oxide-related drugs are suggested in preclinical studies. Consult with a healthcare provider.

Is BPC 157 approved for medical use?

No regulatory approval for human therapeutic use as of current data. It is primarily used in research settings.

Research Sources

https://www.mdpi.com/1424-8247/17/4/461 – This review article summarizes the pleiotropic effects of BPC 157, highlighting its multiple beneficial effects, including tissue healing and cytoprotection. It emphasizes the stable gastric peptide nature of BPC 157, noting its potential for various therapeutic applications. The review is comprehensive but primarily based on preclinical data, lacking human RCTs.
https://www.mdpi.com/1424-8247/18/2/185 – This review focuses on the multifunctionality and mechanisms of BPC 157, detailing mechanisms including angiogenesis and NO system modulation. It discusses the probable low toxicity of BPC 157 based on available data. The review provides mechanistic insights but is primarily preclinical, without meta-analysis of clinical trials.
https://www.wjgnet.com/1007-9327/full/v22/i41/9127.htm – This controlled animal study with rats (n≥30 per group) investigated the effects of BPC 157 on esophagogastric anastomosis healing. Key findings showed that BPC 157 at 10 μg and 10 ng/kg improved healing, increased sphincter pressure, and prevented lethal outcomes (p < 0.05). The study is well-controlled with appropriate statistical significance but is limited by being an animal model without human data.
https://www.globenewswire.com/news-release/2025/05/08/3077611/0/en/Healthletic-BPC-157-Under-Review-Best-Body-Protection-Compound-Oral-Peptides-with-Science-Backed-Results.html – This is a news release discussing Healthletic's BPC-157 product and its potential benefits. It highlights that BPC-157 is under review as a body protection compound with science-backed results. As a news release, it should be interpreted with caution and verified with peer-reviewed research.
https://examine.com/supplements/bpc-157/research/ – Examine.com provides a summary of the research on BPC-157. It compiles and analyzes various studies to provide an overview of the supplement's potential benefits and mechanisms. This resource is useful for a general understanding of the available research.